VTGN
Vistagen Therapeutics
$0.23
+$0.00 (+1.77%)Jul 27, 2026
Key metrics
The numbers that frame VTGN today
- Market cap
- $9.44M
- P/E (TTM)
- -0.1
- EV / FCF
- 0.3
- Gross margin
- 100%
- EV / Sales
- -16.0
- ROIC
- -957.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.20
- 52wk High
- $5.14
Growth
Revenue and earnings trend for VTGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VTGN
Is Vistagen Therapeutics a good buy?
No. Vistagen Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive.
What is the market capitalization of VTGN?
Vistagen Therapeutics's market capitalization is $9.44M.
What is the P/E ratio for VTGN stock?
Vistagen Therapeutics's current P/E ratio is -0.1.
What is the 52-week high for VTGN stock?
The 52-week high for Vistagen Therapeutics is $5.14. The current close of $0.23 is 95.5% below that high.
What is the 52-week low for VTGN stock?
The 52-week low for Vistagen Therapeutics is $0.20. The current close of $0.23 is 16.2% above that low.
Does VTGN stock pay dividends?
Vistagen Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VTGN?
Vistagen Therapeutics's Debt / Equity ratio is 0.03.